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Exploring the effectiveness, efﬁciency and equity
(3e’s) of research and research impact assessment
Saba Hinrichs-Krapels1 and Jonathan Grant1
ABSTRACT The allocation of research funding can beneﬁt greatly from robust analysis of
what has worked in research. In turn, these analyses can help advocacy initiatives and
demonstrate accountability to taxpayers and donors. Capturing and mapping data on the
inputs, processes, outputs, outcome and impact of research is crucial for these analyses. In
this article we argue that the research community as a whole—including funders, researchers
and administrators—is potentially in a position where it can assess or evaluate research not
just according to academic outputs (production of knowledge), but also its outcomes and/or
impact (effects on society). Using an exploratory framework that assesses effectiveness,
efﬁciency and equity (3e’s) of research and research assessment both in terms of academic
outputs and non-academic impact, we also argue that most assessments are primarily
examining the effectiveness of research, as tools are not yet available to systematically
assess research for its efﬁciency and equity. This article is published as part of a special issue
on the future of research assessment.
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Challenges in research impact assessment
Deciding on the appropriate distribution and allocation ofresearch funding in any sector is no easy task. In the caseof the life, biomedical and health sciences, funders making
such decisions may consider the greatest needs in research,
existing gaps in topic or disease areas, or research that has the
potential to demonstrate the greatest breakthroughs and health
returns. While each of these considerations are taken into account
to some extent at national or, in some cases, at a global funding
level, there is little evidence to suggest that this is done
systematically across funders in one country, let alone globally.
Part of the challenge is the lack of accurate data both on the
inputs into research (funding investments), and the accompany-
ing attributed outputs and wider outcomes and impacts. The
Global Forum for Health Research, for example, has published
estimates for global spending on health research for the past 10
years based primarily on surveys conducted by the OECD
(Landriault and Matlin, 2009). In 2014 the UK Clinical Research
Collaboration (UKCRC) published the third UK-wide analysis of
public and charity funded health relevant research since 2004, for
which it used the Health Research Classiﬁcation System (HRCS)
to categorize projects corresponding to £3bn of spend in 2014.
(UK Clinical Research Collaboration, 2015) The UKCRC report
was helpful in demonstrating, for example, that half of all funding
is concentrated in “basic research” (underpinning and aetiology
research) although this proportion to other research has
decreased over the ten-year reporting period. Data were collected
from awards databases from the 64 participating funding
institutions. However, the interpretation of this type of data can
be complex and resource-intensive (Terry et al., 2012), and likely
to be inconsistent if this is to be done across many different
funding institutions globally. Similarly, the inputs and associated
outputs, outcomes and wider impacts of research are also difﬁcult
to track, mainly because the research system has traditionally
relied on academic publications being the main output type that
is systematically tracked and documented, and even that is
seldom attributed directly to funding sources.
In this article, we describe how as a research community
(funders, administrators, researchers and beneﬁciaries) we are
beginning to create more systematic ways of capturing inputs,
and then tracking these to the wider outcomes and impact of
research; but propose that there is still a long way to go. We
explore this by using a framework through which research can be
assessed for public beneﬁt, centering on three broad elements or
“3e’s” of research, shown in Table 1. This framework asks
whether research is effective (that is, does it produce any outputs,
outcomes and/or societal beneﬁts or impact?), efﬁcient (that is,
how productive is the research system? is research happening at
an appropriate “rate”? is there waste in research?), and equitable
(that is, is the research achieving speciﬁc goals, reaching certain
beneﬁciaries, or addressing speciﬁc health needs?).
We acknowledge that in order to systematically answer these
three questions there is an inevitable cost (both to researchers and
to funders), which is spent in collecting and analysing the data
required to assess research. In this article we therefore apply the
same framework as a lens to explore the exercise of assessing
research (that is, whether we have a research) assessment system
that is effective, efﬁcient, and equitable. In effect, we are exploring
two questions: (1) to what extent does the research ecosystem and
community have the infrastructure in place to systematically
assess research (in line with the 3e’s)? and (2) would the
inevitable transaction cost of such systematic assessments be
appropriate?
Conceptualizing 3e’s for research impact assessment
The use of 3e’s as an approach to evaluation in general is not new.
Effectiveness, efﬁciency and equity have been used in a range of
settings, including general programme evaluation (Reinke, 1994),
programme evaluation of quality of health care services
(Donabedian, 1988), evaluating hospital performance (Davis
et al., 2013), health system performance (Aday et al., 1999; Aday,
2004) and health promotion (Tones and Tilford, 2001). Outside of
health, there are also examples of considering 3e’s to assess
proposed options for climate change initiatives (Stern, 2007;
Angelsen, 2009), and achieving value for money in international
development (Department for International Development, 2011;
OECD, 2012). Finally, the 3e’s have been conceptualized and used
in other forms. For example, DFID’s approach to value for money
uses three different terms: economy (where they examine the
inputs to their programmes), efﬁciency and effectiveness (which
includes considerations of outputs that lead to equity) (Department
for International Development, 2011).
Most of these examples relate to the evaluation of delivering a
programme or intervention. While programme evaluation shares
characteristics and methodological approaches with research
impact assessment, the focus in this article is speciﬁcally on how
research is assessed. Research impact assessment can be thought of
as research on research, with the aim of providing analysis that
describes what works in research, helps better allocation of research
funding, creates accountability for research, and supports advocacy
initiatives in policy and practice (Morgan Jones and Grant, 2013).
Previous studies have reviewed the conceptual tools that have
been developed for understanding, assessing and describing
research activity (Banzi et al., 2011; Bornmann, 2013; Guthrie
et al., 2013; Milat et al., 2015; Greenhalgh et al., 2016). The
methods used within these tools include the use of bibliometrics
to assess academic impact, quantitative indicators and metrics on
economic and health outcomes, qualitative narratives and case
studies, and conceptual frameworks such as logic models and
related theories of change. All of these require data on the inputs
of research, and, depending on the questions asked in the
assessment, associated data on outputs, outcomes and impact or a
combination of the three. Figure 1 is a simpliﬁed illustration of
these essential elements of research and how we have con-
ceptualized the 3e’s in the context of these elements. While we are
aware of other conceptual frameworks for describing research
processes (Buxton and Hanney, 1996; CAHS, 2009; Guthrie et al.,
Table 1 | The “3e’s” for assessing research, with associated assessment questions
Simpliﬁed formula Associated assessment questions
Effectiveness Measure outputs for all inputs
INPUT→OUTPUT
Do research inputs lead to outputs, outcomes and impact?
Efﬁciency Measure ratio of OUTPUT/INPUT (for
comparative analysis)
How well do research inputs lead to research outputs?
Equity Determine if OUTPUT achieves X (where
X= speciﬁc goal)
Is the research achieving speciﬁc goals, reaching certain beneﬁciaries, or addressing
speciﬁc health needs?
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2013; Greenhalgh et al., 2016) we are using this simpliﬁed
illustration to contextualize the 3e’s framework. The inputs of
research include the funding invested, knowledge brought in, and
resources required to deliver the research. The research process
includes all the activities that enable the research to happen (ie
reviewing of evidence, data collection, analysis, reporting and so
forth). Asking if these processes are occurring optimally, or if
there is waste, duplication of efforts, or indeed if there is a lack of
productivity when comparing across research groups can assess
the efﬁciency of this process, which we explore further below.
Research activity leads to outputs, outcomes and wider impact,
which can serve to tell us whether research has been effective.
Finally, the information on inputs, research processes and
outputs, outcomes and impact can all serve to determine if
research is equitable. We explore assessment for equity further in
the following sections, but emphasize that we interpret this in this
context as whether the research achieves speciﬁc goals, reaching
certain beneﬁciaries, or addressing speciﬁc health needs.
Applying the 3e’s to research impact assessment
In the following sections we explore these 3e’s further and
demonstrate that the research community as a whole, including
funders, researchers and administrators, is potentially in a
position where it can assess or evaluate research not just
according to academic outputs (production of knowledge), but
also its outcomes and/or impact (effects on society). Such data are
essential in being able to assess research itself for its effectiveness,
efﬁciency and equity and we explore how each of these are
achieved, or could be achieved. Furthermore, we argue that the
various assessments of research that currently exist are primarily
examining the effectiveness of research, and less attention is paid
to whether research is efﬁcient and equitable, mainly because the
tools to do so do not yet exist. There is seldom a systematic
attempt to gather data that shows whether research was produced
in the most optimized way, or benchmarked for performance
(efﬁcient), or if it reached certain beneﬁciaries, or addressed
speciﬁc health needs (equitable).
Effectiveness in research. Taking our simpliﬁed deﬁnition of
effectiveness (Table 1), assessing whether research is effective simply
means ﬁnding out if it produced any outputs, outcomes and/or
societal beneﬁts or impact. The main unit of analysis required is
simply a measure of outputs (or outcomes and/or impact).
At its core, the proximate role of research is to produce new
knowledge and understanding and to build on (or challenge)
previous knowledge, which can then lead to improved under-
standing or beneﬁts to society. The academic and funding
community monitors, audits and/or evaluates research activity
primarily by quality and excellence standards in the production of
knowledge through journal articles, and discussions are ongoing
on how to improve the measurement of “quality” of research
through publications (Boaz et al., 2003). If research is assessed
purely for its production of knowledge (ie academic publications),
then the growth in publications and attempts to ﬁnd the highest
quality output through methods such as bibliometrics may serve
this purpose. Similarly, a combination of publication and patent
data can also demonstrate performance, as exempliﬁed by the
Elsevier report on comparative performance of UK research
(Elsevier, 2013).
If, however, our focus shifts to non-academic societal outcomes
and impact, the tools and methods for gathering this evidence vary.
Publications alone, while capturing the contributions of research in
the knowledge sphere, do not serve to systematically capture the
wider impacts on society arising from research. More recently,
therefore, research funders are collecting extra data to assess
research on its secondary outcomes and beneﬁts to wider society or
“impact”. In the United Kingdom, for example, the Higher
Education Funding Council for England (HEFCE) for the ﬁrst time
based 20% of the overall assessment on non-academic impact in
the 2014 Research Excellence Framework (REF). The National
Institute for Health Research (NIHR), the Medical Research
For example: 
Overall funding into health 
research 
Proportion of funding for 
specific populations/
beneficiaries 
Proportion of funding in 
health or disease 
categories 
For example: 
Impact of research (eg 
REF impact case 
studies) 
Funder-collected output 
data (eg Researchfish) 
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Figure 1 | Essential inputs and outputs, outcomes and impact of the research process used to explore the 3e’s (effectiveness, efﬁciency and equity) in
research assessment.
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Council (MRC) and other funders, including the medical research
charities, collect information beyond publications in their progress
and annual reports. This means we have a rich database available
to us that demonstrates the effectiveness of research.
The ways in which we capture data beyond academic
publications have also developed. For REF 2014, HEFCE chose
to collect information on impact from UK researchers in the form
of “impact case studies” (a four page narrative), which are
available to read in an online searchable database.1 Similarly,
Research Councils and funding bodies in the United Kingdom
regularly collect information (as descriptive text in annual
reports) on the outputs of the research they have funded,
beyond academic publications, and report on these. Much of this
data on wider impacts was initially collected in the form of
reports, using free-text written into word-processing documents.
There are now a growing number of tools to facilitate the
collection of evidence for these wider outcomes/impact; such as
Researchﬁsh®, Symplectic, ImpactStory and Kilola. By adopting
these tools, funders can now also analyse the outputs from funded
projects and report on this. Reports using Researchﬁsh data by
funders including Cancer Research UK, the MRC, and the
Science and Technology Facilities Council, all linked from the
Researchﬁsh website;2 while others such as the Association of
Medical Research Charities are currently working on the analysis
of their Researchﬁsh data.3
In these examples, we can see that most assessments of
research are assessing whether the inputs of research (that is,
funding) are producing outputs (knowledge in the form of
publications), and, more recently, other outcomes or wider
impact. Taking our simpliﬁed deﬁnition of effectiveness in
Table 1, we see that publication lists, tools that collect research
outputs and narrative descriptions of impact to society are
therefore effective ways of demonstrating the “input-output”
pathway of research. The analyses of the 6,679 impact case studies
submitted to REF 2014 concluded that it is possible to extract
useful information on the impact of research through impact case
studies, especially if used in combination with text mining and
other automated tools (King’s College London and Digital
Science, 2015). If the role of research assessment is to assess
whether research inputs are producing outputs and outcomes/
impact, that is, whether research is effective, then all these tools
serve this purpose.
Efﬁciency in research. Efﬁciency is generally reported in terms of
the cost per unit of production (for example, how much does it
cost to produce a number of cars in a production line per year?).
In research it can essentially be used to test research performance
—measuring whether the ratio of output/input of research can be
optimized—by comparing, for example, against other research
programmes or countries (external benchmarking), or to previous
years’ performance (internal benchmarking). We have summar-
ized this in Table 1; the working deﬁnition of efﬁciency in
research asks how well the health research outputs, outcomes and
impact occur. This often implies asking if there is waste in
research, which means we now need two units for analysis: inputs
and outputs (or outcomes and/or impact).
Efﬁciency in terms of academic outputs using a crude output/
input ratio already occurs. In 1997, the UK Chief Scientist Robert
May (May, 1997), as well as Grant and Lewison (1997) were the
ﬁrst to calculate publications and citations per funding spent by
country. The UK Department for Business, Innovation and Skills
has since published similar calculations in their reports that assess
the performance of the United Kingdom compared with 7 other
research-intensive countries (Elsevier, 2013). However, efﬁciency
in terms of wider outcomes and impact, the connection between
inputs and outcomes/impact are not clearly linked, making this
calculation much more challenging. Taking the example of the
REF 2014 process, which was largely peer-review based, the data
were not available to conduct systematic, rigorous benchmarking
of research outcomes and impact. The impact data was available
in the form of narrative text, with no requirement to produce
standardized reporting of the reach and signiﬁcance of impact.
For example, in our own analysis of these narrative texts, we had
envisaged being able to extract quantitative information and to
group such information by various indicators, thus enabling us to
develop return-on-investment type estimates (King’s College
London and Digital Science, 2015). However, this was not feasible
as there was a very large amount of numerical data in the case
studies that were inconsistently used and that would need
converting to standard units. Financial information was expressed
in different currencies, while measures and calculations of health
gains (in terms of quality adjusted life years, or QALYs) were
inconsistent. To calculate a crude estimate of total health gain, we
had to supplement and manipulate the data in the case studies
given by the authors with external data cited in their references or
using our own judgement (King’s College London and Digital
Science, 2015). Morevoer, the actual input data was not available
at all, as researchers were not required (thankfully) to link each
individual impact to a funding source or proportions thereof.
One could foresee, however, a scenario in which this
information is captured systematically in more standardized
units, whereby the impact of different research projects or
programmes can be compared against each other, if project or
programme outputs and impact were also linked to funding. For
example, the ratio of health gains per £1 achieved in one project
(in the form of QALYs) could be compared with the ratio of
health gains per £1 spent in another (and if indeed the research
investment, or inputs, of such outcomes could be attributed to
one or more funding sources). Tools such as Researchﬁsh that
link inputs to research outputs could in future enable such
calculations to allow at least funding bodies to make decisions
about which research is working more efﬁciently. Within the
Researchﬁsh platform, research outputs (and outcomes and
impact) are gathered through a “question set” that range from
academic publications to patents and commercialization activ-
ities, to informing policy, products, and interventions. Research-
ers can attribute these entries to research grants and awards,
thereby enabling funders to capture a range of data that have been
submitted by the researchers they fund and evaluate the impact of
their research funding by various units of assessment (for
example, disciplinary focus, research funding mechanism, host
institution and so on). Such evaluations strengthen accountability
to the taxpayer and donor communities, and can be used to assess
the effectiveness of different aspects of research funding (Hinrichs
et al., 2015). Tools such as these, if used extensively, could
provide funders with agile ways to discover how work across their
research portfolio is progressing and what it is producing (such as
knowledge, leverage and connections) and enable assessing for
efﬁciency with more standardized data. Further considerations
would then have to be made on whether efﬁciency is more
important, than say, equity considerations, and we note the
challenge of trade-offs in our discussion.
In addition to data linking challenges, another challenge to
benchmarking impacts for comparisons in efﬁciency, there are no
standardized measures of what constitutes a good impact story,
nor which types of research are producing valuable impacts. It has
recently been shown that both the general public and researchers
value impact in different ways, which calls for the development of
future generic measures of “impact utility” using micro-economic
approaches such as contingent valuation and discrete choice
modeling (Pollit et al., 2016). At present, therefore, a systematic
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“output/input” or “outcome (and impact)/input” calculation,
taken to be our working deﬁnition for efﬁciency in Table 1, is not
strictly used, with the exception of studies that benchmark
publication and citation per £ spent (Elsevier, 2013). An
alternative approach is to measure the rate of return of research,
with a view to compare efﬁciencies of these across funding
programmes, disease areas, or countries’ investments in research.
There are examples where research beneﬁts have been quantiﬁed
within a disease area, such as cancer (Glover et al., 2014) and
cardiovascular research (Buxton et al., 2008), but limited data
availability and the associated necessary assumptions mean that
direct comparisons on return on assessment should be avoided.
There is also a body of work that acknowledges that there may
be inefﬁciencies in research, and therefore efforts should be made
to reduce waste in research (Chalmers et al., 2014). In 2009,
Chalmers and Glasziou (2009) had previously estimated that the
cumulative effect was that about 85% of research investment is
wasted—not taking into account the inefﬁciencies in regulation
and management of research. We note that the concept of waste
requires some critical reﬂection and deﬁnition. While in some
ﬁelds, duplicating studies could indicate waste (since existing
rigorous studies may have already answered relevant health-
related questions), in others such duplication is necessary in order
to validate ﬁndings which may not yet be deﬁnitive. Furthermore,
most research systems include an element of competition, which
is regarded as beneﬁcial to the research process and may mean
that multiple researchers may be tackling the same research
questions at the same time, thereby encouraging optimized
innovation rather than waste. Nevertheless, the principle of
reﬂecting on potential waste still applies in these considerations.
Waste can be reduced by ensuring new research builds on
previous research and/or best practice, for example, by requiring
systematic reviews as part of the research proposal, as encouraged
by initiatives such as the EBRNetwork (http://ebrnetwork.org); by
making protocols available to the public to ensure study designs
build on previous experience; by encouraging publication of raw
data (for example, clinical trial data via IMPACT, http://
ottawagroup.ohri.ca/disclosure.html); and by encouraging open
access and making research ﬁndings more accessible and promote
and build on knowledge “efﬁciently”. The NIHR in the United
Kingdom has been identiﬁed as championing reduction of waste
in research by requiring systematic reviews for any application
submitted to them, involving patients and the public in decision
making, and making full protocols available for a number of
their research projects (https://monanasser.wordpress.com/2015/
12/03/how-to-reduce-waste-in-research-from-edinburgh-to-vienna-
and-sarajevo; http://www.nihr.ac.uk/funding/pgfar-application-
process.htm).
As a research community and ecosystem, therefore, while we
do not yet systematically assess research outputs, outcomes and
wider impacts for its efﬁciency, the tools are available to do so.
Furthermore, the initiatives to reduce waste a priori, that is, at
grant application assessment stage, suggest that there is will-
ingness in the research community to reduce waste in research
and promote efﬁciency in research. However, if the role of
research assessment is to assess whether research inputs are
producing outputs and outcomes/impact at an appropriate rate, ie
whether research is efﬁcient, then better tools are required to link
these outputs to research inputs and systematically make such
comparisons, especially for research outcomes and impacts that
are not counted in the same way as academic publications.
Equity in research. Assessing research for equity involves setting
priorities for research; ensuring that inputs and outputs, out-
comes and impact are aligned to intended equitable social goals
(which include, for example, eliminating extremes of wealth and
poverty, avoiding neglect of speciﬁc disease areas, ensuring gen-
der and race equality). Deciding on those particular goals depends
on exactly where equity needs to be achieved. Another way to
achieve equity is through the equitable funding of researchers,
that is, ensuring that the allocation of health research funding
(inputs) is done equitably and without biases (for example of
gender, age and institutional ranking). In this article, however,
because we are focusing on the outcomes and impact of research,
we are not referring to equitable funding but rather the need to
conduct research assessment to achieve equity. Consequently, we
acknowledge that in order to achieve equity will require a value
judgement by those making the decisions on how funds are
distributed. This helps us distinguish equity from a broader
concept such as diversity (Stirling, 2007), as the intention is to
encourage careful thought on allocating research funds according
to pressing social goals. A helpful deﬁnition for equity in this
context is the distribution of beneﬁts in a target population in
relation to individual needs (Roemer, 1980; Reinke, 1994), which
could be health needs.
Identifying health needs and matching these to funding
allocation, however, can be challenging (Guindo et al., 2012).
To be equipped to consider equity in research assessment, data is
needed on how the outputs, outcomes and impact of research
have contributed to speciﬁc health needs, or speciﬁc beneﬁciaries
of research. We describe three challenges with respect to research
assessment for equity below.
Firstly, there is a challenge in mapping health expenditure
overall. Few funders publicly report disaggregated statistics on
health R&D expenditures, and there is a lack of uniformity in the
use of R&D classiﬁcation systems across different funders (Terry
et al., 2012). There have been some initiatives that have begun to
address the ﬁrst challenge, such as the WHO Global Health
Observatory which identiﬁes gaps in health R&D (WHO, 2016).
Second, there are challenges in identifying and then prioritizing
health needs when it comes to research allocation. In the
aforementioned 2014 UKCRC, burden of disease (measured using
Disability Adjusted Life Years or DALYs’) was matched with
HRCS to identify differences between health research funded and
burden of disease (UK Clinical Research Collaboration, 2015). An
analysis by Rottingen et al. of research investment and
subsequent outputs conﬁrm that there are substantial gaps in
the global landscape of health R&D, especially for and in low-
income and middle-income countries (Røttingen et al., 2013).
Viergever (2013) has also demonstrated a mismatch between the
health R&D that is needed and that which is undertaken,
especially in the areas of neglected diseases, neglected popula-
tions, and neglected products such as diagnostics and platform
technologies, because of the favoured investments in drugs and
vaccines (Viergever, 2013). Part of the challenge, he argues, is that
R&D is not needs-driven, there is no system to facilitate the
prioritization of health needs, and, ﬁnally, the research system is
largely dependent on market incentives. Furthermore, the role of
other stakeholders outside the research community can also
inﬂuence prioritization. For example, private investment in
research can also be driven primarily by expected rate of return,
which can distort equity considerations. Increasingly, public
engagement has a role in setting priorities for health research,
which can support its societal legitimacy and provide validation
for making value judgements in prioritizing research needs.
Finally, the challenge shared with the consideration of
“efﬁciency” in research assessment, is that we do not have
systematic and standardized reporting on who beneﬁts and “what
works” in research funding (ie the outcomes and impact
components of Fig. 1). The “gap maps” from the International
Initiative for Impact Evaluation, 3ie, for example, demonstrate
PALGRAVE COMMUNICATIONS | DOI: 10.1057/palcomms.2016.90 ARTICLE
PALGRAVE COMMUNICATIONS | 2:16090 |DOI: 10.1057/palcomms.2016.90 |www.palgrave-journals.com/palcomms 5
what is known and not known from impact evaluations and
systematic reviews in particular areas such as education, HIV and
AIDS, or agriculture (3IE, 2016). Gathering the data for this,
however, can be challenging. For example, the latest edition of
Millions Saved by the Center for Global Development has
identiﬁed cases of proven success in global health (Glassman and
Temin, 2016), but this required issuing public calls for submissions
of good practice, reviewing systematic reviews databases and
conducting interviews with subject matters. Women, for example,
may be disadvantaged as the beneﬁciaries of research, in terms of
its health, societal and economic impacts (Sen et al., 2007;
Kuhlmann and Annandale, 2015; Schiebinger et al., 2011-2015).
There is evidence to suggest that research that does not account for
gender differences can result in inaccurate conclusions about how
women respond to disease and this in turn will inﬂuence the
effectiveness of treatment choices (Bartlett et al., 2005; Johnson
et al., 2014).
Much more has been written on the subject of equity in
research, and we will not attempt to list all the evidence nor enter
into discussion about how equity is judged, as such arguments
could generate different subjective views. However, we list the
above examples to demonstrate the existence of activity in this
area, and to state that to bring equity into research impact
assessment, data still needs to be collected systematically.
Ultimately, this will help prioritize resource allocation and we
acknowledge this will still require value judgements. As discussed
earlier, while the data on research inputs and processes is
collected by different funders, that of outcomes and impact are
not yet done in a systematic and standardized format.
3e’s in research assessment processes
We have so far examined whether current assessment processes
are capable of assessing research for its 3e’s, and have argued that
despite good will, there are still infrastructure and data collection
and data sharing challenges to overcome. We now explore 3e’s in
the process of assessing research.
Around the world most assessment for research performance
are based on number and/or quality of publications, including
Norway, Sweden, Canada, Australia, Italy, Denmark, Spain and
Finland, and the Czech Republic (Krapels et al., 2016). There has
been some debate on whether peer review and bibliometrics are
the right tools for assessing research, but they are broadly
accepted as key tools to assess research outputs (academic
outputs). In practice, we also see much of the information on
research outputs, outcomes and impact used effectively—for
example, data collected through tools such as Researchﬁsh have
enabled funders such as the MRC to make strategic decisions
about what works in their research funding portfolio (Hinrichs
et al., 2015).
The assessment of non-academic outcomes and impact is
relatively new, and therefore more difﬁcult to assess given the lack
of systematic and standardized reporting of these (as noted
earlier). Following REF 2014, HEFCE commissioned a number of
evaluations and reviews of its assessment process, including an
independent review of the REF commissioned by government to
also provide conclusions and suggestions for the next assessment
cycle (Stern, 2016). If we simply wish to answer whether or not
the assessment process worked, ie whether or not it is effective as
a means of capturing research performance, then we would argue
that to a large extent this was the case in REF 2014 (Manville
et al., 2015a, b).
What has not been yet demonstrated, however, is whether
research assessment is efﬁcient (or whether it is “too expensive” to
justify). Research assessment entails an inevitable transaction
cost, both to the funder in analysing the outputs and to the
research organizations who need to prepare the data to
demonstrate outputs. Processes such as peer review have been
noted to have substantial costs for upholding quality (Wessely,
1998) and questions have been raised about its cost-effectiveness
(and indeed overall effectiveness) (Godlee et al., 1999).
The total transaction costs for both the universities and
funding councils for REF 2014 were 2.4% of the total money
allocated (Technopolis, 2015). To investigate whether these
ﬁgures were higher or lower than expected, we conducted a brief
search to ﬁnd comparable transaction costs elsewhere—both in
research assessment and in other areas. In our search to ﬁnd
comparable examples we found there were two ways in which
transaction costs of assessment were reported: (i) private or
internal transaction costs of organizations being assessed in
preparing for assessment (such as universities’ internal costs in
preparing REF submissions), and (ii) costs for undertaking
assessments for the assessor or funder (usually expressed as a
percentage of their total expenditure). We show a sample we
found in Table 2, which includes the total transaction costs
(including both to the assessor and the institutions being assessed,
such as HEIs). The resulting ﬁgures are not intended to compare
like for like, as each calculation differs in the methods employed
in estimating individual costs, but serve to give a rough
representation of transaction costs.
What we concluded from this table is ﬁrst that direct
comparisons are challenging, given the varying ways in which
these estimates were calculated. Costs are more often shown in
terms of direct costs to the organization doing the assessment (as
in (ii) above, since this is easier to calculate for one single
organization, rather than turning to the various assessed
organizations to calculate their time spent in preparing for the
assessment). An example of this is a report by Morton et al.,
which compares administration as a percentage of total budget
for UK funders such as the Wellcome Trust, MRC and DFID,
which range from 2.8 to 7.1% of their total budget (Morton et al.,
2012). There is one example from another sector which could be
comparable to assessment preparations (as in costs (i) above),
which are farmer’s transaction costs (private transaction costs)
incurred as a proportion of the premium received for being part
of an agri-environmental scheme reported as high as 25%
(Mettepenningen et al., 2009). We also note that the ﬁgures for
RCUK for example may be higher if calculated today given the
fall in success rates (although potentially balanced out again with
efﬁciency gained in internal administration since then). Although
we cannot make complete conclusions about how transaction
costs of assessment in higher education compare with other forms
of assessment in other sectors, we can observe that these costs
vary and the process of assessment has the potential to become
more efﬁcient.
Finally, considerations of equity within the research assessment
process can also drive how individuals, projects and institutions
are assessed and rewarded. There is evidence to suggest that
performance assessment can serve to either encourage or
discourage equity in the distribution of research. Gender inequity,
for example, could arise as a result of gender bias in both research
and research assessment; women traditionally have received fewer
awards than men, are less included as beneﬁciaries of research,
and are cited less (Ovseiko et al., 2016). Research impact
assessment, if motivated and driven by equitable principles, can
become an engine for creating equity in the allocation of research
funding (Ovseiko et al., 2016). Part of what may need to improve
are the methods we employ within research assessment to avoid
inequity or unequal opportunity. For example, the use of a
mixture of disciplines, and incorporating diversity in review
panels, can aid in avoiding unconscious biases among the panel.
Adopting the appropriate method, whether it is peer review, the
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use of metrics, or alternative methods, is therefore important. In
the independent review of the role of metrics in research
assessment and management, a correlation analysis was under-
taken to compare the use of individual metrics with the outcomes
of the REF peer review process (Wilsdon et al., 2015). The review
found evidence to suggest statistically signiﬁcant differences in
the correlation with REF scores for early-career researchers and
women in a small number of Unit of Assessment (Wilsdon et al.,
2015).
Concluding thoughts
The allocation of research funding can beneﬁt greatly from robust
analysis of what has worked in research, and, in turn, these
analyses can help advocacy initiatives and demonstrate account-
ability to taxpayers and donors. Capturing and mapping data on
the inputs, processes, outputs, outcome and impact of research is
crucial for these analyses and helps conduct research on research.
We have argued here that the research community as a whole,
including funders, researchers and administrators, is potentially
in a position where it can assess or evaluate research not just
according to academic outputs (production of knowledge), but
also its outcomes and/or impact (effects on society). Using an
exploratory framework that assesses 3e’s of research and research
assessment, we also argue that most assessments are primarily
examining the effectiveness of research, as tools are not yet
available to systematically assess research for its efﬁciency and
equity.
We have also made a distinction between general evaluation
and research impact assessment, emphasizing that the latter
allows for better allocation of research funding, creates account-
ability for research, and supports advocacy initiatives in policy
and practice (Morgan Jones and Grant, 2013). Each of the 3e’s are
important considerations for improving assessments for these
purposes and can help answer crucial funding policy questions.
Essentially the 3e’s framework can help answer the following
policy questions with regards to research funding: Which of our
funding programmes are effective? Which funding programmes
are most efﬁcient? How do we allocate research funding? And,
ﬁnally, is the transactional cost worth it?
Furthermore, we acknowledge that these 3e’s are not
necessarily reinforcing and combining them may involve trade-
offs. For example, it has been argued that “equity” still struggles to
ﬁnd its place as an equal among traditional public administration
values of 3e’s (Norman-Major, 2011). In his application of 3e’s to
programme evaluation, Reinke (1994) rightly points out, for
example, that the high cost of equitably serving hard-to-reach
members of the population may require efﬁciency considerations
to be compromised. However, we echo Reinke’s sentiments that
these considerations are informative and important in their own
right and are increasingly being used in evaluation and
assessment in this same or similar forms. Therefore not only is
it important to consider what the research funding policy
questions are in relation to these 3e’s, but the associated
inevitable value judgements that will be required. We suggest
that this framework does not replace such judgements but helps
supports those decisions.
We acknowledge that this 3e’s framework needs further
reﬁnement and invite readers to examine it critically. Our
purpose in writing this is driven by the fact that assessments
occur anyway, and signiﬁcant investments have gone into
reviewing them. The recently published Stern review of the
Research Excellence Framework was based on the assumption
that research assessment exercises have contributed productively
to driving competition and fostering research excellence (Stern,
2016). The existence of the review itself also points to the need forT
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recommendations for shaping future assessment exercises. To
consider the 3e’s in research assessment, especially in the
systematic manner that we are suggesting, there will be inevitable
transaction costs. Our crude comparisons have shown these may
actually be comparatively small, although implementing much of
what we suggest here could increase those costs. To manage those
costs the research community and infrastructure would have to
be tailored to systematically capture the information needed for
such assessments. The 3e’s of research assessment provides an
alternative approach on how research assessment can be framed
so that it more holistically addresses research funding challenges,
while remaining mindful of the realistic transaction costs that
could be incurred.
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